ENDOSCOPIC DISINFECTION GUIDELINES

MALAYSIAN SOCIETY OF
GASTROENTEROLOGY & HEPATOLOGY

2006

Panel Members:
Dr. Ryan Ponnudurai
Assoc. Prof. Dr. Sanjiv Mahadeva
Dr. Abraham George
Mary Bong



Flexible endoscopes are complex reusable instruments that require unique consideration with respect to decontamination. In addition to the external surface of endoscopes, their internal channels are exposed to body fluids and other contaminants.

Transmission of infection at endoscopy
A guiding principle for disinfection is that of universal precautions: any patient must be considered a potential infection risk, and each endoscope must be decontaminated with the same rigour following every endoscopic procedure.There have been concerns regarding the transmission of Hepatitis C virus (HCV) following an instance report in 1997 (1). Adherence to the following reprocessing guidelines should effectively eliminate the risk of HCV transmission from endoscopy.

During the last 20 years glutaraldehyde based products have been the most commonly used disinfectants in endoscopy units worldwide. Most reports of transmission of bacteria such as pathogenic E. Coli, Salmonella, Pseudomonas, Enterobacter and Serratia spp. predate the introduction of glutaraldehyde for disinfection. (2)

Three types of micro organisms have merited particular attention in recent years. (3)

  1. Mycobacteria: The emergence of multi drug resistant strains of Mycobacterium tuberculosis and the high incidence of infections with M.avium intracellulare among HIV infected patients has led to a greater awareness for transmission during bronchoscopy. Mycobacterium in general are extremely resistant to glutaraldehyde.
  2. Bacterial spores (Bacillus and Clostridium): Spores from these organisms have been isolated from endoscopes but there has been no reported cases of transmission of these infections by endoscopy.
  3. Pathological Prions including Creutzfeld Jacob Disease: These infection organisms are extremely resistant to standard decontamination procedures. (4)

General Considerations:
Sterilisation is defined as the complete destruction of all micro-organisms including bacterial spores. Sterilisation is required for devices that are normally used in sterile areas of the body (e.g. laparoscopes, microsurgical instruments). Flexible endoscopes (which make contact with mucous membranes but do not ordinarily penetrate normally sterile areas of the body) are generally reprocessed by high level disinfection rather than sterilisation in order to kill bacteria, viruses, mycobacteria and some spores. Most flexible gastrointestinal endoscopes would not withstand the conditions normally used in a steam sterilisation process.

Endoscopes are routinely exposed to mucus and other gastrointestinal secretions, blood, saliva, faeces, bile, and sometimes pus. The process of decontamination comprises two basic components:

a)


manual cleaning, which includes brushing with single-use wire brushes, and exposure of all external and accessible internal components to a low-foaming enzymatic detergent known to be compatible with the endoscope;
b) automatic disinfection, rinsing and drying of all exposed surfaces of the endoscope.

Failure to follow these recommendations may not only lead to transmission of infection, but also to misdiagnosis (e.g. if pathological material from one patient is included in specimens from the next patient) and to instrument malfunction and shortened lifespan.

Decontamination should begin as soon as the endoscope has been removed from the patient
The initial steps in the reprocessing protocol begin in the procedure room immediately after removal of the insertion tube from the patient and before removing the endoscope from the power source.

Have the following available :

Immediately after removing the endoscope from the patient, wipe the insertion tube with a wet cloth or sponge soaked in the freshly prepared enzymatic detergent solution.

Place the distal end of the endoscope into the enzymatic detergent solution. Suction the solution through the biopsy/suction channel until the solution is visibly clean. Alternate suctioning detergent solution and air several times. Finish by suctioning air.

Cleaning the Endoscope in the Reprocessing Area:
Have the following available:

LEAK TESTING:
Leak test the endoscope following manufacturer's instructions.

Follow the manufacturer's instructions if a leak is detected or the endoscope appears damaged.

CLEANING:
Mechanical cleaning is the first and most important step in removing the microbial burden from an endoscope. Retained debris may inactivate or interfere with the capability of the active ingredient of the high level disinfectant to effectively kill and/or inactivate microorganisms. Cleaning gastrointestinal endoscopes is necessary before automated or manual disinfection.

USING HIGH LEVEL DISINFECTION (HLD):

CHOICE OF DISINFECTANTS
The ideal disinfectant would be:

Other factors that will influence the choice of disinfectant include the process of dilution, stability of the solution, number of reuses possible, and the cost of using the particular disinfectant (e.g. costs of the appropriate automatic endoscope reprocessors, storage space, and conditions required for use, including staff protection measures).

Although less irritant than glutaraldehyde, orthophthalaldehyde, peracetic acid and chlorine dioxide are all potential skin and respiratory sensitisers. Therefore the same precautions should be taken when using these disinfectants, including fume extraction/containment and personal protective equipment.

Disinfectants commonly used:

a) Aldehyde-based disinfectants
 

A widely-used glutaraldehyde-based disinfectant (Cidex ®) is still widely used in Malaysia but has recently been withdrawn from the United Kingdom market by its manufacturer. This is not only because there have been advances in the development of disinfectants with superior bactericidal activity, but also because glutaraldehyde is chemically related to formaldehyde, and has similar toxic effects on skin and mucous membranes.(4) Resulting adverse effects include severe dermatitis, conjunctivitis, sinusitis and asthma. Glutaraldehyde has also been implicated as a cause of chemical colitis.(5) A further problem with glutaraldehyde-based disinfectants is their potential to cross-link residual protein material. The resulting amalgam is very difficult to remove from working channels of endoscopes that have been repeatedly flushed with aldehydes. This again underscores the importance of manual pre-cleaning and brushing of all accessible internal channels and valve chambers before disinfection.

Glutaraldehyde and its derivatives kill most bacteria and viruses (including human immunodeficiency virus and hepatitis B) in less than five minutes. Mycobacteria are more resistant to 2% glutaraldehyde, and thus, the recommendation is that endoscopes are immersed for 20 minutes in 2% glutaraldehyde at room temperature.(6)

Ortho-phthalaldehyde (0.55% solution marketed as Cidex OPA ®) is more stable and has a lower vapour pressure than glutaraldehyde. It is therefore practically odourless and does not emit noxious fumes. OPA is a potential skin and respiratory sensitiser and thus can aggravate pre-existing asthma, bronchitis or dermatitis. It is non-flammable and is stable at a wide pH range. It has better myobactericidal activity than 2% glutaraldehyde.(7) In use testing of OPA on endoscopes has shown cidal activity achieving a reduction of greater than five logs. and stability over a two-week period. The manufacturers of Cidex OPA ® recommend the daily use of OPA test strips to monitor the activity of reused batches of disinfectant solution. Each batch should be replaced after two weeks of use. OPA does not require pre-activation and can be discarded down hospital drains. It does not appear to damage instrument components, but like other aldehydes it can stain and cross-link protein material.

   
b) Peracetic Acid
 

This is marketed as NuCidex ® (0.35 % peracetic acid), Perasafe ® (0.26% peracetic acid), Perascope ® and Gigasept PA. Peracetic acid is also available as part of a dedicated disinfector called the Steris ® system (which uses 0.2% peracetic acid at 53ºC) Peracetic acid is a powerful oxidising agent that rapidly kills a wide range of micro-organisms. It has a broad spectrum of activity against viruses, vegetative bacteria, mycobacteria, fungi and spores. Its mycobactericidal activity is superior to that of glutaraldehyde, being effective against mycobacteria (including Mycobacterium avium) within 10 minutes.(8) Peracetic acid is more effective than glutaraldehyde at removing organic matter such as biofilms. Its rate of activity varies according to its use concentration and temperature. Bactericidal activity diminishes after 24 hours and therefore each batch should be changed each day. Peracetic acid can cause discolouration and peeling of electroplated components and rubber. The Steris ® system has been shown to be effective at eliminating vegetative organisms, fungi and spores and was effective in experimental models of antimicrobial efficacy.(9) The main drawbacks with the Steris ® system are that exposure to detergent is not included in its wash cycle, the instruments must be allowed to cool before use, and the instrument tray shape is unsuitable for the disinfection of Olympus ® endoscopic ultrasound scopes.

Peracetic acid is a colourless liquid with a strong vinegary odour which is irritant, but it decomposes to carbon dioxide, oxygen and water and therefore does not pose an environmental hazard. The WATCH committee of the Health and Safety Committee have concluded that peracetic acid can cause skin reactions, and that there is a potential for provoking upper respiratory irritation. Peracetic acid should therefore be used with an exhaust ventilated system.


MANUAL DISINFECTION:

RINSING AFTER MANUAL DISINFECTION:

DRYING:

STORAGE:

AUTOMATED ENDOSCOPIC REPROCESSORS (AER's):

SUMMARY:

  1. Decontamination of endoscopes should be undertaken at the beginning and the end of each list, and between patients, by trained staff in dedicated rooms. Thorough manual cleaning with an enzymatic detergent, including the brushing of all accessible endoscope channels, must be undertaken before automatic endoscope disinfection.

  2. All disinfectants should be used at the correct temperature in accordance with the manufacturers' instructions. Some manufacturers provide test strips and/or kits, the use of which they recommend in ensuring optimal activity of their product.

  3. It is important to ensure that the endoscope manufacturer has approved the chosen disinfectant for use in decontaminating their product, and that the disinfectant is also compatible with the automatic endoscope reprocessor in which it is being used.

  4. Two percent glutaraldehyde has historically been the most commonly used disinfectant in endoscopy units within the UK. Unfortunately this agent is irritant and sensitising, and adverse effects among endoscopy staff are common. The manufacturers of a widely-used glutaraldehyde-based product have now withdrawn this disinfectant largely due to health and safety concerns.

  5. The use of isopropyl alcohol for flushing endoscope channels is recommended as part of the drying process at the end of the working day prior to storage.

  6. Automated endoscope reprocessing machines should be used for all endoscope decontamination following manual precleaning. These machines are recommended both because they reliably expose all external and internal components of the endoscope to thorough disinfection and rinsing, and because they help prevent atmospheric pollution by the disinfectant. Automatic reprocessors must be reliable, effective and easy to use. Manual disinfection is no longer acceptable.

  7. Water used in automatic endoscope reprocessors should be free of particulate contamination and of micro-organisms. This can be achieved either by using bacteria-retaining filters or by other methods, for example the addition of biocides. In-line water softeners may be needed if the local supply delivers hard water. The final rinse water should be sampled from the automatic reprocessor and tested for its microbiological quality at least weekly.

  8. A record should be kept of the serial number of each endoscope used in each patient. This log should include any loan endoscopes. This is important for any future contact tracing when possible endoscopic transmission of disease is being investigated.

  9. Endoscopy should be avoided whenever possible in patients with suspected or confirmed vCJD. When deemed essential either a dedicated endoscope should be used, or one nearing the end of its useful life can be employed and subsequently quarantined and reserved for similar patients in future. When percutaneous feeding gastrostomy or jejunostomy is required in such patients a dedicated endoscope should be used or the feeding tube deployed by radiological or surgical means.

  10. The agent of variant Creutzfeldt-Jakob disease (vCJD) is resistant to all forms of conventional sterilisation. The risk of transmission of this agent is probably extremely low provided that scrupulous attention to detail is routinely employed in the decontamination process after every patient. In particular all accessible endoscope channels should be brushed through with a single use purpose-made brush tipped wire assembly that has an appropriate length and diameter for each channel.

  11. 'Single use' or autoclavable accessories are preferred. Single use biopsy forceps, guidewires and cytology brushes should always be used in order to minimise any possible risk of transmitting prion disease. Rubber valves covering the working channel must be changed after all procedures involving the passage of biopsy forceps, guidewires and/or other accessories through the endoscope.

  12. Health surveillance of staff is mandatory and should include a pre-employment enquiry regarding asthma, skin and mucosal sensitivity problems and lung function by spirometry. Occupational health records should be retained for 40 years.

  13. Those involved in endoscopic practice should be immunised in accordance with local occupational health and infection control policies. All staff should wear single use gloves that are changed after each procedure. Staff involved in endoscope decontamination should also wear appropriate protective clothing.

References

  1. Bronowicki JP, Vernard V, Botte C et al. Patient-to-patient transmission of hepatitis C virus during colonoscopy. New Engl J Med 1997;337:237-40.
  2. Technology Status Evaluation Report; Transmision of infection by gastrointestinal endoscopy. Gastrointest Endosc 2001;54:824-8.
  3. BSG Guidelines for decontamination of Equipment for Gastrointestinal Endoscopy. BSG workingpart report 2003(Updated 2005). The report of a working party of the British Society of Gastroenterology Endoscopy Committee
  4. Axon ATR, Beilenhoff U, Bramble MG et al. E.S.G.E Guidelines: Variant Creutzfeldt-Jakob Disease (vCJD) and gastrointestinal endoscopy. Endoscopy 2001; 33: 1070-80.
  5. Axon ATR, Beilenhoff U, Bramble MG et al. ESGE Guidelines on Cleaning and Disinfection in GI endoscopy. Endoscopy 2000;32(1):77-83.
  6. West AB, Kuan SF, Bennick M et al. Glutaraldehyde colitis following endoscopy: clinical and pathological features and investigation of an outbreak. Gastrointest Endosc 1995;108:1250-5.
  7. Cronmiller JR, Nelson DK, Salman G et al. Antimicrobial efficacy of endoscopic disinfection procedures: a controlled, multifactorial investigation. Gastrointest Endosc 1999;50:152-8.
  8. Walsh SE, Maillard JY, Russell AD. Orthophthalaldehyde: a possible alternative to glutaraldehyde for high level disinfection. J Appl Microbiol 1999;86:1039-46.
  9. Lynam PA, Babb JR, Fraise AP. Comparison of the mycobactericidal activity of 2% alkaline glutaraldehyde and NuCidex ®" (0.35% peracetic acid). J Hosp Infect 1995;30:237-40.
  10. Bradley CR, Babb JR, Ayliffe GA. Evaluation of the Steris System 1 Peracetic Acid Endoscope Reprocessor. J Hosp Infect 1995;29(2):143-51.

return to main page